Hélène Chevrou‐Séverac

1.0k total citations
28 papers, 691 citations indexed

About

Hélène Chevrou‐Séverac is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, Hélène Chevrou‐Séverac has authored 28 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 6 papers in Surgery and 5 papers in General Health Professions. Recurrent topics in Hélène Chevrou‐Séverac's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Nutrition and Health in Aging (5 papers) and Inflammatory Bowel Disease (4 papers). Hélène Chevrou‐Séverac is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Nutrition and Health in Aging (5 papers) and Inflammatory Bowel Disease (4 papers). Hélène Chevrou‐Séverac collaborates with scholars based in Switzerland, United Kingdom and United States. Hélène Chevrou‐Séverac's co-authors include Donna Rowen, John Brazier, Roberta Ara, Ben van Hout, Hélène Karcher, Clémentine Nordon, Adeline Abbé, Lucien Abenhaim, Mikkel Zöllner Ankarfeldt and Michel Rossignol and has published in prestigious journals such as Schizophrenia Research, Psychiatric Services and Clinical Nutrition.

In The Last Decade

Hélène Chevrou‐Séverac

24 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélène Chevrou‐Séverac Switzerland 13 378 145 106 74 74 28 691
Francis Pang United Kingdom 9 236 0.6× 132 0.9× 236 2.2× 61 0.8× 59 0.8× 27 692
Anja Jacobs Germany 19 93 0.2× 116 0.8× 80 0.8× 107 1.4× 98 1.3× 39 978
R. Akehurst United Kingdom 17 243 0.6× 90 0.6× 69 0.7× 222 3.0× 69 0.9× 34 1.0k
Brett Doble United Kingdom 17 230 0.6× 97 0.7× 64 0.6× 116 1.6× 88 1.2× 46 743
Kun-Sei Lee South Korea 15 81 0.2× 170 1.2× 56 0.5× 39 0.5× 100 1.4× 74 767
Alı́cia Granados Spain 14 205 0.5× 151 1.0× 106 1.0× 244 3.3× 197 2.7× 34 878
Jelka Zaletel Slovenia 11 107 0.3× 105 0.7× 93 0.9× 116 1.6× 250 3.4× 32 841
Igor Karp Canada 17 67 0.2× 106 0.7× 60 0.6× 112 1.5× 72 1.0× 45 958
Lynda McKenzie United Kingdom 13 138 0.4× 158 1.1× 106 1.0× 57 0.8× 66 0.9× 24 704
Tanya G. K. Bentley United States 16 174 0.5× 129 0.9× 58 0.5× 102 1.4× 59 0.8× 44 715

Countries citing papers authored by Hélène Chevrou‐Séverac

Since Specialization
Citations

This map shows the geographic impact of Hélène Chevrou‐Séverac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Chevrou‐Séverac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Chevrou‐Séverac more than expected).

Fields of papers citing papers by Hélène Chevrou‐Séverac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Chevrou‐Séverac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Chevrou‐Séverac. The network helps show where Hélène Chevrou‐Séverac may publish in the future.

Co-authorship network of co-authors of Hélène Chevrou‐Séverac

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Chevrou‐Séverac. A scholar is included among the top collaborators of Hélène Chevrou‐Séverac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Chevrou‐Séverac. Hélène Chevrou‐Séverac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balijepalli, Chakrapani, et al.. (2021). Quality of Life in Wilson’s Disease: A Systematic Literature Review. Journal of health economics and outcomes research. 8(2). 105–113. 5 indexed citations
2.
Chevrou‐Séverac, Hélène, et al.. (2021). Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores. Applied Health Economics and Health Policy. 20(1). 119–131. 8 indexed citations
3.
4.
Brazier, John, Roberta Ara, Jan J.V. Busschbach, et al.. (2019). Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. Value in Health. 22(3). 267–275. 110 indexed citations
5.
Nicholson, Lindsay, et al.. (2017). Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?. ClinicoEconomics and Outcomes Research. Volume 9. 327–342. 27 indexed citations
6.
Nordon, Clémentine, Mark Belger, Javier Jiménez, et al.. (2017). Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database. Schizophrenia Research. 193. 146–153. 7 indexed citations
7.
Olariu, Elena, Kevin Cadwell, Elizabeth Hancock, David Trueman, & Hélène Chevrou‐Séverac. (2017). Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review. ClinicoEconomics and Outcomes Research. Volume 9. 537–546. 19 indexed citations
8.
Wilson, Michele, et al.. (2017). Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK. ClinicoEconomics and Outcomes Research. Volume 9. 641–652. 13 indexed citations
9.
Brazier, John, Roberta Ara, Donna Rowen, & Hélène Chevrou‐Séverac. (2017). A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. PharmacoEconomics. 35(S1). 21–31. 96 indexed citations
10.
Ara, Roberta, Tessa Peasgood, Clara Mukuria, et al.. (2017). Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care. PharmacoEconomics. 35(S1). 7–9. 4 indexed citations
11.
Wilson, Michele, et al.. (2017). Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. The European Journal of Health Economics. 19(2). 229–240. 27 indexed citations
12.
Rowen, Donna, et al.. (2017). International Regulations and Recommendations for Utility Data for Health Technology Assessment. PharmacoEconomics. 35(S1). 11–19. 119 indexed citations
13.
14.
Olariu, Elena, et al.. (2016). Recommendations for the Calculation of Transition Probabilities in Markov Cohort Models: A Targeted Literature Review. Value in Health. 19(7). A373–A373. 1 indexed citations
15.
Nordon, Clémentine, Hélène Karcher, Rolf H. H. Groenwold, et al.. (2015). The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization. Value in Health. 19(1). 75–81. 111 indexed citations
16.
Walzer, Stefan, et al.. (2014). Health economic analyses in medical nutrition: a systematic literature review. ClinicoEconomics and Outcomes Research. 6. 109–109. 10 indexed citations
17.
Chevrou‐Séverac, Hélène, et al.. (2013). Systematic Review: The Economic Burden of Crohn’s Disease in Europe in Adults and Children. Value in Health. 16(7). A496–A496.
18.
Doig, Gordon S., Hélène Chevrou‐Séverac, & F. O. Simpson. (2013). Early enteral nutrition in critical illness: a full economic analysis using US costs. ClinicoEconomics and Outcomes Research. 5. 429–429. 27 indexed citations
19.
Chevrou‐Séverac, Hélène, Christophe Pinget, Yannick Cerantola, et al.. (2013). Cost-effectiveness analysis of immune-modulating nutritional support for gastrointestinal cancer patients. Clinical Nutrition. 33(4). 649–654. 15 indexed citations
20.
Peytremann‐Bridevaux, Isabelle & Hélène Chevrou‐Séverac. (2008). Economic Grand Rounds: Financial Burden of Medical Care and Risk of Forgoing Care Among Europeans With Depressive Symptoms. Psychiatric Services. 59(8). 840–842. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Pang Breakdown of academic impact, for papers by Anja Jacobs Breakdown of academic impact, for papers by R. Akehurst Breakdown of academic impact, for papers by Brett Doble Breakdown of academic impact, for papers by Kun-Sei Lee Breakdown of academic impact, for papers by Alı́cia Granados Breakdown of academic impact, for papers by Jelka Zaletel Breakdown of academic impact, for papers by Igor Karp Breakdown of academic impact, for papers by Lynda McKenzie Breakdown of academic impact, for papers by Tanya G. K. Bentley
Rankless by CCL
2026